| Page No 1 |
| Phrase | Consultant | Town | Special Interests |
| antibacterial drug development | *Consultant(s)* | *Towns* | Antimicrobial resistance, infection outcomes research, antimicrobial pharmacokinetics and dynamics, antibacterial drug development, medical microbiology |
| child development | *Consultant(s)* | *Towns* | Neurodevelopmental paediatrics, child development, special educational needs, safeguarding, social communication disorders |
| Child development | *Consultant(s)* | *Towns* | Child development, neurodisability, looked-after children, assessment of autism and ADHD |
| Child development and disability | *Consultant(s)* | *Towns* | Child development and disability, child abuse, ADHD, autism, adoption and fostering, paediatric medico-legal issues |
| children with disorders of sex development - DSD | *Consultant(s)* | *Towns* | Children of short stature, children with disorders of sex development - DSD, adolescents with gender dysphoria |
| continuous professional development | *Consultant(s)* | *Towns* | General adult psychiatry, psychopharmacology, continuous professional development, forensic psychiatry |
| development disorders | *Consultant(s)* | *Towns* | Paediatric neurology, paediatric epilepsy, movement disorders, development disorders, paediatrics, paediatric neuromuscular conditions |
| development neuropsychiatry | *Consultant(s)* | *Towns* | Early onset psychoses, development neuropsychiatry, paediatric psychopharmacology, inpatient treatment in children |
| Development of cancer vaccines | *Consultant(s)* | *Towns* | Development of cancer vaccines, adoptive T-cell therapy of cancer, gene therapy of cancer |
| development of Neurotrauma Services | *Consultant(s)* | *Towns* | Neurotrauma, head injuries, spine injuries, complex cranial neurosurgery, development of Neurotrauma Services, skull base surgery, neuroendoscopic procedures, management of complex CSF - cerebrospinal fluid disorders |
| development of new treatments for psychosis | *Consultant(s)* | *Towns* | Mechanisms underlying psychotic symptoms and psychosis, development of new treatments for psychosis |
| device development and evaluation (CE-marking) | *Consultant(s)* | *Towns* | Diagnostic and interventional neuroradiology, design and set up of clinical trials, device development and evaluation (CE-marking), high-fidelity medical simulation, reference site (core laboratory for clinical trials), set up of thrombectomy services |
| disorders of sexual development | *Consultant(s)* | *Towns* | Paediatric endocrinology and diabetes, metabolic bone disease, skeletal dysplasias, disorders of sexual development |
| disorders/differences in sex development in children | *Consultant(s)* | *Towns* | Late endocrine effects of oncological treatment and congenital hyperinsulinism in children, disorders/differences in sex development in children |
| drug development | *Consultant(s)* | *Towns* | Ischaemic heart disease, heart failure, cardiac electrophysiology, pacemaker/ICD - implantable cardioverter defibrillator implantation, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, upper gastrointestinal cancer, melanoma, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, drug development, ovarian cancer, endometrial cancer, cervical cancer, early phase clinical trials |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, immunotherapy, targeted therapy, cancer biomarkers, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, drug development, breast cancer, colorectal cancer |
| drug development - childhood cancer | *Consultant(s)* | *Towns* | Paediatric neuro-oncology, drug development - childhood cancer, the biology of childhood malignant glioma, drug development |
| DSD - disorders of sex development | *Consultant(s)* | *Towns* | Paediatric endocrinology, growth, puberty, bone growth, thyroid, pituitary, DSD - disorders of sex development |
| early drug development | *Consultant(s)* | *Towns* | Medical oncology, genito-urinary oncology, translational oncology, early drug development |
| foreskin development | *Consultant(s)* | *Towns* | Paediatric A&E, paediatric oncology, nutrition in surgical patients, foreskin development, foreskin problems, undescended testes, Currarino trial |
| gastrointestinal immunity and infections and vaccine development | *Consultant(s)* | *Towns* | IBD - inflammatory bowel disease, Crohn's disease, ulcerative colitis, gastrointestinal immunity and infections and vaccine development, nutrition and irritable bowel syndrome - IBS, dyspepsia and reflux disease, feeding tube placement and nutrition, endoscopic ultrasound and laser therapy |
| growth and development | *Consultant(s)* | *Towns* | Paediatric endocrinology, neuroendocrine and late effects of childhood malignancy, adolescence to 21yrs, growth and development, reproductive maturity, Turner's syndrome, congenital adrenal hyperplasia, short stature, paediatric endocrine oncology, pituitary tumours in childhood |
| guideline development | *Consultant(s)* | *Towns* | Paediatric rheumatology, juvenile idiopathic arthritis, guideline development, chronic recurrent multifocal osteomyelitis - CRMO/CNO, uveitis associated with juvenile idiopathic arthritis |
| healthcare pathway development | *Consultant(s)* | *Towns* | Adult ADHD, autism, healthcare pathway development, depressive disorder, schizophrenia |
| imaging in drug development | *Consultant(s)* | *Towns* | Diagnostic radiology, MRI, CT, oncology, functional MRI, imaging in drug development, prostate MRI |
| International development | *Consultant(s)* | *Towns* | International development, adult psychiatry, transcultural psychiatry |
| leadership development | *Consultant(s)* | *Towns* | Echocardiography, valve disease, transoesophageal echo, leadership development |
| management and service development | *Consultant(s)* | *Towns* | Leadership, management and service development, enhanced care |
| mental health outcome development | *Consultant(s)* | *Towns* | Old age psychiatry, dementia, depression, mental health outcome development, public mental health |
| new drug development in paediatric oncology | *Consultant(s)* | *Towns* | Brain tumours in childhood, liver tumours in childhood, bone and soft tissue tumours in childhood, new drug development in paediatric oncology |
| patient and carer involvement in service development | *Consultant(s)* | *Towns* | ADHD in children with learning disabilities, patient and carer involvement in service development |
| phase 1 drug development | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, phase 1 drug development |
| pituitary development | *Consultant(s)* | *Towns* | Paediatric endocrinology, pituitary development, septo-optic dysplasia |
| service development and clinical leadership | *Consultant(s)* | *Towns* | Palliative medicine, pain management and complex system control, advance care planning, service development and clinical leadership, postgraduate medical education, patient safety and risk management |
| urology guideline development | *Consultant(s)* | *Towns* | Reconstructive urology, incontinence, neurourology, urodynamics, haematuria, bladder cancer, radical cystectomy, bladder reconstruction, urology guideline development |
| Page No 1 |
